QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 543 in last 24h · 103,602 total before filter · latest 9m ago
543last 24h
2522last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: ABTSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?
Insider Monkey8d agoneutral
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?

Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Sales for the quarter rose 13% on a reported basis and 4.8% on a comparable basis. Let’s dive deeper […]

Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
Insider Monkey58d agobullish
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock

Abbott Laboratories (NYSE:ABT) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 27, analyst David Roman from Goldman Sachs maintained a “Buy” rating on the company’s stock and reduced the price objective to $113.00 from $121.00. The analyst’s rating is supported by several factors that highlight improvements in fundamentals and an attractive […]